Table of Contents Author Guidelines Submit a Manuscript
Clinical and Developmental Immunology
Volume 2009 (2009), Article ID 374696, 4 pages
http://dx.doi.org/10.1155/2009/374696
Research Article

Does Toxoplasma gondii Infection Affect the Levels of IgE and Cytokines (IL-5, IL-6, IL-10, IL-12, and TNF-alpha)?

Department of Clinical Laboratory Diagnostics, Medical University of Bialystok, J. Waszyngton'a 15A, 15-269 Bialystok, Poland

Received 23 December 2008; Accepted 18 March 2009

Academic Editor: Bernhard Fleischer

Copyright © 2009 Joanna Matowicka-Karna et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. Evering and L. M. Weiss, “The immunology of parasite infections in immunocompromised hosts,” Parasite Immunology, vol. 28, no. 11, pp. 549–565, 2006. View at Publisher · View at Google Scholar
  2. S. M. Hegab and S. A. Al-Mutawa, “Immunopathogenesis of toxoplasmosis,” Clinical and Experimental Medicine, vol. 3, no. 2, pp. 84–105, 2003. View at Publisher · View at Google Scholar
  3. M. Lappalainen and K. Hedman, “Serodiagnosis of toxoplasmosis. The impact of measurement of IgG avidity,” Annali dell'Istituto Superiore di Sanita, vol. 40, no. 1, pp. 81–88, 2004. View at Google Scholar
  4. L. A. Suzuki, R. J. Rocha, and C. L. Rossi, “Evaluation of serological markers for the immunodiagnosis of acute acquired toxoplasmosis,” Journal of Medical Microbiology, vol. 50, no. 1, pp. 62–70, 2001. View at Google Scholar
  5. G. Biesiada, A. Kalinowska-Nowak, J. Czepiel, and T. Mach, “Toxoplasmosis—epidemiology, clinical manifestation and infection in pregnant women,” Przegląd Lekarski, vol. 63, no. 2, pp. 97–99, 2006. View at Google Scholar
  6. M. B. Nickdel, F. Roberts, F. Brombacher, J. Alexander, and C. W. Roberts, “Counter-protective role for interleukin-5 during acute Toxoplasma gondii infection,” Infection and Immunity, vol. 69, no. 2, pp. 1044–1052, 2001. View at Publisher · View at Google Scholar
  7. C. Lang, U. Groß, and C. G. K. Lüder, “Subversion of innate and adaptive immune responses by Toxoplasma gondii,” Parasitology Research, vol. 100, no. 2, pp. 191–203, 2007. View at Publisher · View at Google Scholar
  8. S. Romagnani, “Understanding the role of Th1/Th2 cells in infection,” Trends in Microbiology, vol. 4, no. 12, pp. 470–473, 1996. View at Publisher · View at Google Scholar
  9. J. Vilcek and T. H. Lee, “Tumor necrosis factor: new insights into the molecular mechanisms of its multiple actions,” Journal of Biological Chemistry, vol. 266, no. 12, pp. 7313–7316, 1991. View at Google Scholar
  10. P. Zaccone, Z. Fehervari, J. M. Phillips, D. W. Dunne, and A. Cooke, “Parasitic worms and inflammatory diseases,” Parasite Immunology, vol. 28, no. 10, pp. 515–523, 2006. View at Publisher · View at Google Scholar
  11. C. Studeničová, G. Benčaiová, and R. Holková, “Seroprevalence of Toxoplasma gondii antibodies in a healthy population from Slovakia,” European Journal of Internal Medicine, vol. 17, no. 7, pp. 470–473, 2006. View at Publisher · View at Google Scholar
  12. M. Paul, “Use of the ISAGA method in detection of specific IgM, IgA, IgE antibodies in acquired and congenital toxoplasmosis,” Wiadomości Parazytologiczne, vol. 43, no. 1, pp. 39–51, 1997. View at Google Scholar
  13. U. Gross, O. Keksel, and M. L. Dardé, “Value of detecting immunoglobulin E antibodies for the serological diagnosis of Toxoplasma gondii infection,” Clinical and Diagnostic Laboratory Immunology, vol. 4, no. 3, pp. 247–251, 1997. View at Google Scholar
  14. Z. Dziubek, H. Zarnowska, W. Basiak, A. Górski, and P. Kajfasz, “Some aspects of immune response in toxoplasmosis,” Przeglad Epidemiologiczny, vol. 55, no. 4, pp. 495–502, 2001. View at Google Scholar
  15. L. H. Faccioli, B. B. Vargaftig, A. I. Medeiros, and A. Malheiros, “Cytokines in the modulation of eosinophilia,” Memórias do Instituto Oswaldo Cruz, vol. 92, supplement 2, pp. 109–114, 1997. View at Publisher · View at Google Scholar
  16. L. H. Faccioli, A. I. Medeiros, A. Malheiro, R. C. L. R. Pietro, A. Januario, and B. B. Vargaftig, “Interleukin-5 modulates interleukin-8 secretion in eosinophilic inflammation,” Mediators of Inflammation, vol. 7, no. 1, pp. 41–47, 1998. View at Publisher · View at Google Scholar
  17. M. B. Nickdel, R. E. Lyons, F. Roberts et al., “Intestinal pathology during acute toxoplasmosis is IL-4 dependent and unrelated to parasite burden,” Parasite Immunology, vol. 26, no. 2, pp. 75–82, 2004. View at Publisher · View at Google Scholar
  18. D. Filisetti and E. Candolfi, “Immune response to Toxoplasma gondii,” Annali dell'Istituto Superiore di Sanita, vol. 40, no. 1, pp. 71–80, 2004. View at Google Scholar
  19. E. H. Wilson, U. Wille-Reece, F. Dzierszinski, and C. A. Hunter, “A critical role for IL-10 in limiting inflammation during toxoplasmic encephalitis,” Journal of Neuroimmunology, vol. 165, no. 1-2, pp. 63–74, 2005. View at Publisher · View at Google Scholar
  20. O. Liesenfeld, “Immune responses to Toxoplasma gondii in the gut,” Immunobiology, vol. 201, no. 2, pp. 229–239, 1999. View at Google Scholar
  21. K.-N. Kang, I.-U. Choi, D.-W. Shin, and Y.-H. Lee, “Cytokine and antibody responses of reactivated murine toxoplasmosis upon administration of dexamathasone,” The Korean Journal of Parasitology, vol. 44, no. 3, pp. 209–219, 2006. View at Publisher · View at Google Scholar